Prof Stephen Harrap
Honorary (Professor Emeritus)
Department of Anatomy and Physiology
457 Scholarly works
23 Projects
HIGHLIGHTS
2026
Journal article
Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study
DOI: 10.1111/dom.706082026
Journal article
Blood Pressure Parameters and Risk of Cognitive Decline and Dementia in Type 2 Diabetes: Results From the ADVANCE Trial
DOI: 10.1161/JAHA.125.0440612026
Journal article
Female HFpEF diastolic dysfunction and premature mortality is accentuated relative to male in an experimental HFpEF model – a specific cardiac lipid accumulation
DOI: 10.1016/j.jmccpl.2025.1007792026
Journal article
Peripheral autonomic dysregulation in response to standing: a new form associated with cardiovascular disease, mobility reduction, and cognitive alterations.
DOI: 10.1093/eurheartj/ehaf11202020
Journal article
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
DOI: 10.1093/eurheartj/ehaa7942017
Research Grant
New Camkii Therapeutic Targets in Heart Failure With Preserved Ejection Fraction
2017
Research Grant
Y Chromosome Mechanisms in Coronary Artery Disease
RECENT SCHOLARLY WORKS
2025
Journal article
Relationship between time-varying achieved HbA 1c and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: The ADVANCE study
DOI: 10.1136/bmjdrc-2024-0047132025
Conference Proceedings
HEALTHY LIFESTYLE FACTORS AND COMBINED MACROVASCULAR AND MICROVASCULAR EVENTS IN DIABETES PATIENTS WITH HIGH CARDIOVASCULAR RISK: RESULTS FROM ADVANCE
DOI: 10.1097/01.hjh.0001115444.26522.aa2025
Journal article
Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial
DOI: 10.2337/figshare.277319042025
Journal article
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial
DOI: 10.1016/j.cccb.2024.1003722025
Journal article
Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
DOI: 10.1186/s12916-025-03932-32024
Journal article
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study
DOI: 10.1111/dom.15935
RECENT PROJECTS
2000
Research Grant
Advance 2000-2007: RCC Clinical Trial
2016
Research Grant
Local Cardiac Sex Steroids - New Therapeutic Targets